Drugmakers Mallinckrodt, Endo in talks to merge, source says
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
Douglas Budget1d
Donatella Versace, fashion icon who saved slain brother's brand
Donatella Versace, whose departure as creative director of the family-founded luxury label was announced Thursday, overcame tragedy and self-doubt to reinvent herself as head of one of Italy's leading ...
US FDA's Top Lawyer Hilary Perkins Resigns Two Days Into Role
(Reuters) -The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a ...
RFK Jr. wants to eliminate FDA’s controversial food additive program. Here’s why that matters
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
Scientific American7h
Scientist’s Study Led FDA to Ban Red No. 3 Food Dye. Yet He Says It Is Safe
Joseph Borzelleca published a study on the food coloring Red No. 3. The FDA cited his work when banning the additive in ...
FDA top lawyer resigns days after starting job
The U.S. Food and Drug Administration’s (FDA) chief counsel resigned two days after her appointment, according to a Thursday announcement from the agency. “Hilary K. Perkins has ...
FDA chief counsel who defended abortion pill access under Biden resigns two days into job
Recently selected Food and Drug Administration chief lawyer Hilary K. Perkins has resigned from the job, according to a post ...
Kennedy Asks FDA to Revise 'Self-Affirm' Rule for Food Ingredient Safety
"For far too long, ingredient manufacturers and sponsors have exploited a loophole that has allowed new ingredients and ...
CNN3d
RFK Jr. wants to eliminate FDA’s controversial food additive program. Here’s why that matters
Former FDA Commissioner Dr. Robert Califf, who resigned from his position on January 20, added that any reform would have to make it past the powerful food industry lobby, which has traditionally ...
Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action Against TransMedics Group, Inc. (TMDX)
If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected].
Allarity announces final settlement with SEC including $2.5M civil penalty
Therapeutics has reached a final settlement with the U.S. Securities and Exchange Commission relating to the previously ...